Catalyst Pharmaceuticals
CPRX
#3601
Rank
C$5.52 B
Marketcap
C$45.11
Share price
0.00%
Change (1 day)
58.24%
Change (1 year)

EPS for Catalyst Pharmaceuticals (CPRX)

EPS in 2026 (TTM): C$2.50

According to Catalyst Pharmaceuticals's latest financial reports the company's current EPS (TTM) is C$2.59. In 2025 the company made an earnings per share (EPS) of C$2.52 an increase over its 2024 EPS that were of C$1.99.

EPS history for Catalyst Pharmaceuticals from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$2.50-1.02%
2025C$2.5226.62%
2024C$1.99
2022C$1.15110.53%
2021C$0.54-47.22%
2020C$1.03132.26%
2019C$0.44-191.18%
2018C-$0.4954.55%
2017C-$0.32-4.35%
2016C-$0.33-8%
2015C-$0.36

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$9.57 269.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$1.02-60.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$3.87 49.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
C-$3.77-245.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
C-$72.07-2,879.56%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C-$0.13-104.97%๐Ÿ‡บ๐Ÿ‡ธ USA